MDT - Medtronic plc
| Previous Close | 97.50 |
| Open | 97.60 |
| Bid | 97.05 x 1000 |
| Ask | 97.95 x 1000 |
| Day's Range | 97.37 - 98.16 |
| 52 Week Range | 81.66 - 100.15 |
| Volume | 3,056,859 |
| Avg. Volume | 5,675,745 |
| Market Cap | 130.718B |
| Beta (3Y Monthly) | 0.53 |
| PE Ratio (TTM) | 28.59 |
| EPS (TTM) | 3.41 |
| Earnings Date | Aug 20, 2019 |
| Forward Dividend & Yield | 2.00 (2.16%) |
| Ex-Dividend Date | 2019-03-21 |
| 1y Target Est | 103.17 |
- Investor's Business Daily•2 days ago
Why This Method Of Replacing A Faulty Heart Valve Is Gaining Steam
A nonsurgical method of heart-valve replacement, dubbed TAVR, is gaining steam in the U.S. — propping up medical technology companies Edwards and Medtronic, an analyst said Friday.
- TheStreet.com•2 days ago
Dexcom Looks Like It Can Finally Break Out on the Topside
For his "Executive Decision" segment of Mad Money Thursday night, Jim Cramer spoke with Kevin Sayer, chairman, president and CEO of Dexcom Inc. The trend-following Moving Average Convergence Divergence (MACD) oscillator just moved above the zero line for an outright buy signal on this time frame.
- American City Business Journals•3 days ago
DHL plans to add 50 jobs, invest millions of dollars in Memphis facilities
Logistics firm DHL Supply Chain will expand its medical device and pharmaceutical logistics business in Memphis, bringing about 50 more jobs and $8 million in capital investment.
- Zacks•5 days ago
Medtronic Delivers Favorable Outcome on Guardian Connect
Medtronic's (MDT) data indicates that Guardian Connect will enable patients to better understand glucose trends and increase Time in Range.
- Markit•5 days ago
See what the IHS Markit Score report has to say about Medtronic PLC.
Medtronic PLC NYSE:MDTView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MDT with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MDT. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MDT had net inflows of $5.04 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
GlobeNewswire•6 days agoReal-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
June 10, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced real-world data on its Guardian(TM) Connect continuous glucose monitoring (CGM) system and Sugar.IQ(TM) diabetes assistant app presented at the 79th Scientific Sessions of the American Diabetes Association (ADA) Annual Meeting in San Francisco. The data presented were recorded by users of the Guardian Connect system paired with Sugar.IQ diabetes assistant, a separate first-of-its-kind intelligent app that continually analyzes how an individual`s glucose levels respond to food intake, insulin dosages, daily routines and other factors1. The Sugar.IQ app combines data from the Guardian Connect system with artificial intelligence technology from Medtronic`s strategic partner, IBM® Watson Health, to detect important patterns and trends for people with diabetes and help them make more informed decisions on how to better manage glucose levels and stay within target range.
- Insider Monkey•6 days ago
Is Medtronic plc. (MDT) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]
- Investor's Business Daily•6 days ago
How The David Of Diabetes Devices Is Taking On Goliath — And Why Shares Dipped
Tandem Diabetes stock skidded Monday as investors questioned whether the medical devices maker could catch up to industry leader Medtronic in diabetes treatment using a pump and monitor.
- GlobeNewswire•6 days ago
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
Four Year Partnership Made Public Today DUBLIN - June 10, 2019 - To enable upcoming regulatory filings, Medtronic plc (NYSE:MDT) today made public its partnership with KARL STORZ SE & Co. KG (Tuttlingen, ...
- GlobeNewswire•8 days ago
Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
June 8, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company`s pivotal trial of its Bluetooth® enabled MiniMed(TM) 780G advanced hybrid closed loop (AHCL) system. This next-generation system is designed to automate the delivery of correction boluses when the user experiences, or is predicted to experience, prolonged high glucose levels based on their sensor readings. The trial will evaluate the safety of the MiniMed 780G system in participants with type 1 diabetes at home, at work, during exercise and other daily activities.
- GlobeNewswire•8 days ago
Medtronic Initiates Pivotal Trial for Next-Generation Guardian(TM) Continuous Glucose Monitoring Sensor
June 8, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced that it has initiated the company`s pivotal trial for its next-generation Guardian(TM) continuous glucose monitoring (CGM) sensor designed to improve accuracy and overall system performance, reduce sensor calibrations and enhance overall user experience. The multi-center, prospective trial will study the next-generation CGM sensor in up to 460 participants with type 1 or type 2 diabetes aged two to 80 years old over the course of seven days. Study participants will be randomly assigned to sensor wear location and testing days and times.
- GlobeNewswire•8 days ago
Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management
June 7, 2019 - Medtronic plc (MDT), the global leader in medical technology, services and solutions, and Tidepool, a 501(c)(3) nonprofit organization dedicated to making diabetes data more accessible, actionable and meaningful, have agreed to work together to create an interoperable automated insulin pump system. Medtronic will develop a future Bluetooth-enabled MiniMed(TM) pump that would be compatible with Tidepool Loop, a future FDA-regulated, open source automated insulin delivery app for iPhone® and Apple Watch® currently in development. "We think that Medtronic is making a very bold and important move here that shows tremendous courage and is the absolutely right thing for the diabetes community," said Howard Look, founder and CEO of Tidepool.
- TheStreet.com•10 days ago
Medtronic Is Edging Closer to an Upside Breakout on the Charts
Sometimes CEO's deserve the benefit the of the doubt, Jim Cramer reminded viewers on Mad Money. In this daily bar chart of MDT, below, we can see a number of bullish developments. The daily On-Balance-Volume (OBV) line has been in an uptrend the past 12 months and recently made a new high for the move up.
- Benzinga•11 days ago
Wells Fargo: Medtronic An Accelerating Growth Story Trading At A Discount
Medtronic PLC (NYSE: MDT ) has earned a bullish review from Wells Fargo Securities, which premised its optimistic outlook on the company's growth prospects. The Analyst Larry Biegelsen upgraded Medtronic ...
- GuruFocus.com•14 days ago
Weekly Top Insider Buys Highlight for the Week of May 31
The largest Insider Buys this week were for Medtronic PLC (MDT), General Electric Co. (GE), Keurig Dr Pepper Inc. (KDP) and Phillips 66 (PSX). Director Richard H. Anderson bought 10,900 shares of MDT stock on May 24 at the average price of $92.4. Warning! GuruFocus has detected 5 Warning Signs with MDT.
- Investor's Business Daily•16 days ago
Medtech Stocks Hit The Brakes As Trump Proposes Mexican Tariffs
Medical technology companies Intuitive Surgical and Medtronic could feel the pressure as President Donald Trump ratchets up tariffs on Mexican imports, beginning June 10, an analyst says.
- Zacks•17 days ago
Medtronic Receives FDA Nod for SelectSite Catheter System
The launch of the SelectSite catheter is in line with Medtronic's (MDT) goal to expand its cardiac care portfolio.
- GlobeNewswire•18 days ago
Medtronic Chairman and CEO Omar Ishrak to Speak at Goldman Sachs Global Healthcare Conference
May 29, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, in Rancho Palos Verdes, California. Omar Ishrak, Medtronic chairman and chief executive officer, will answer questions about the company beginning at 11:20 a.m. PDT (1:20 p.m. CDT). Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world`s largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.
- GlobeNewswire•18 days ago
Medtronic Gains U.S. FDA Clearance for New Catheter System for HIS Bundle Pacing
May 29, 2019 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) clearance and commercial launch for the SelectSite(TM) C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing (HBP). The SelectSite C304-HIS deflectable catheter system features a deflectable, out-of-plane curve to reach the bundle of His and is designed to enable enhanced range maneuverability, fixation and implant success for a wider range of patient anatomies. The new catheter system facilitates placement of the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing lead, the only pacing lead on the U.S. market approved for HBP.
- Investopedia•18 days ago
The Top Health Care Companies in the World
An introduction to health care companies that are tops in their fields. From health care provider to pharmaceuticals, these companies have the largest global presence according to market capitalization. Learn who these health care giants are and why they may be a good investment.
- Market Realist•18 days ago
What Is Medtronic Guiding for Its Business Segments in 2020?
Is Medtronic an Attractive Pick after Its Q4 Results?(Continued from Prior Part)Revenue growth guidanceOn its fourth-quarter earnings conference call, Medtronic (MDT) guided for YoY (year-over-year) organic revenue growth of 4.5%–5% for its
- Barrons.com•18 days ago
3 Dividend Stock Picks From an Income Fund Manager
Phil Davidson, a longtime co-manager of the American Century Equity Income Fund, notes that the highest-yielding stocks haven’t performed all that well in recent years.
- Thomson Reuters StreetEvents•19 days ago
Edited Transcript of MDT earnings conference call or presentation 23-May-19 12:00pm GMT
Q4 2019 Medtronic PLC Earnings Call
- GlobeNewswire•19 days ago
Medtronic EVP & CVG President Mike Coyle to Speak at Jefferies 2019 Global Healthcare Conference
May 28, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced it will participate in the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019, in New York City. Mike Coyle, executive vice president and president of Medtronic`s Cardiac and Vascular group (CVG), will answer questions about the company beginning at 11:00 a.m. EDT (10:00 a.m. CDT). A live audio webcast of the session will be available on June 5, 2019, by clicking on the Investors Events link at http://investorrelations.medtronic.com. An archived audio file will be available for replay on the same webpage later in the day.
